SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 78180.72
104.35 (-0.13%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Anuh Pharma Ltd.	Q V+ PT	809 Small Cap	78.93 (-2.24%)	19.71	2.3	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Shree Ganesh Remedies Ltd.	Q V PT	842 Small Cap	652.95 (-0.43%)	47.37	5.16	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Astrazeneca Pharma India Ltd.	Q V PT	20,556 Small Cap	8,200.05 (-0.27%)	109.62	23.55	15.59	20.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Anthem Biosciences Ltd.	Q V PT	43,617 Mid Cap	767 (-0.93%)	65.05	13.84	13.62	19.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Morepen Laboratories Ltd.	Q V PT	3,330 Small Cap	61.16 (0.63%)	50.42	2.68	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Abbott India Ltd.	Q V PT	57,058 Mid Cap	26,712.05 (-0.52%)	36.76	11.95	9.38	18.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	CORONA Remedies Ltd.	Q V+ PT	12,251 Small Cap	1,988.50 (-0.73%)	66.28	16.42	19.49	18.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Vijaya Diagnostic Centre Ltd.	Q V+ PT	13,879 Small Cap	1,335.15 (-1.01%)	80.23	14.5	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Supriya Lifescience Ltd.	Q V+ PT	6,968 Small Cap	841.65 (-2.78%)	33.32	5.82	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Concord Biotech Ltd.	Q V PT	13,433 Small Cap	1,271.65 (-0.96%)	51.48	6.66	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	40,668 Mid Cap	2,402.90 (0.10%)	39.26	17.81	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Kovai Medical Center & Hospital Ltd.	Q V+ PT	6,580 Small Cap	6,015.85 (0.05%)	26.92	4.99	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Krishna Institute of Medical Sciences Ltd	Q V PT	34,592 Small Cap	805.45 (-2.20%)	132.69	8.8	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Acutaas Chemicals Ltd.	Q V+ PT	28,772 Small Cap	3,392.35 (-3.47%)	78.57	17.25	32.80	16.82	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Dr. Reddys Laboratories Ltd.	Q V PT	1,14,246 Mid Cap	1,353.75 (-1.10%)	27.23	3.03	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Gujarat Themis Biosyn Ltd.	Q V+ PT	4,197 Small Cap	377.10 (-2.10%)	89.91	14.59	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Windlas Biotech Ltd.	Q V PT	1,773 Small Cap	851.75 (-0.84%)	26.68	3.45	16.15	15.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Innova Captab Ltd.	Q V PT	5,466 Small Cap	969.40 (1.50%)	65.31	6.16	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	SMS Pharmaceuticals Ltd.	Q V+ PT	3,935 Small Cap	424.35 (1.00%)	44.91	4.89	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Glenmark Pharmaceuticals Ltd.	Q V+ PT	64,072 Mid Cap	2,263.45 (-0.31%)	47.05	6.1	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Kopran Ltd.	Q V PT	931 Small Cap	189.60 (-1.71%)	30.64	2.08	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,63,246 Large Cap	4,854.25 (0.64%)	75.46	19.46	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Dr. Lal Pathlabs Ltd.	Q V PT	28,275 Small Cap	1,678.15 (-0.50%)	55.64	11.75	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Mankind Pharma Ltd.	Q V PT	1,04,911 Mid Cap	2,531.50 (-0.34%)	51.49	6.4	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,193 Small Cap	128.45 (-4.46%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Procter & Gamble Health Ltd.	Q V+ PT	10,493 Small Cap	6,251.55 (-1.10%)	32.1	20	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Advanced Enzyme Technologies Ltd.	Q V PT	3,615 Small Cap	320.90 (-0.59%)	27.42	5.09	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Lincoln Pharmaceuticals Ltd.	Q V PT	1,230 Small Cap	620.65 (1.11%)	13.99	1.62	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	9,826 Small Cap	650.60 (4.21%)	88.02	4.05	10.00	11.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Sai Life Sciences Ltd.	Q V+ PT	26,166 Small Cap	1,215.30 (-1.40%)	76.63	10.43	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
IOL Chem & Pharma	164.95	14.23%
Natco Pharma	984.35	5.65%
Bliss GVS Pharma	511.55	4.69%
Akums Drugs & Pharma	650.60	4.21%
Gland Pharma	2,551	3.60%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Fermenta Biotech	369.50	-6.46%
KMC Speciality Hosp.	128.45	-4.46%
Biocon	406.90	-4.18%
Kwality Pharma	2,548.05	-3.96%
Themis Medicare	116.65	-3.60%

News about Top Pharma Companies in India

Jul, 2026

Corona Remedies informs about compliances-certificate

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as amended from time to time, Corona Remedies has enclosed a copy of the certificate received from Bigshare Services, Registrar to Issue and Share Transfer Agent of the Company, for the first quarter ended on June 30, 2026.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Concord Biotech informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has enclosed copies of the newspaper advertisements published for the information of the shareholders, in compliance with the applicable provisions of the SEBI Listing Regulations and the Companies Act, 2013, read with the rules made thereunder. The advertisements contain information regarding the Company's 41st Annual General Meeting, notice of candidature for the office of Director, the record date, and the availability of the e-voting facility. Financial Express (English, All Editions); and Financial Express (Gujarati, Ahmedabad Editions).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals informs about press release

Glenmark Pharmaceuticals has informed about the launch of Olanzapine for Injection, 10 mg/vial, Single?Dose Vial. Glenmark’s Olanzapine for Injection is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa® IntraMuscular Injection 10 mg/vial, of Cheplapharm Registration GmbH [NDA 021253]. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals’ arm launches Olanzapine for Injection

The launch of Olanzapine for Injection underscores its strategic focus on growing a robust injectables portfolio and strengthening its presence within the institutional channel

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Yatharth Hospital & Trauma Care Services Ltd.	8,131 Crore
2	3B Blackbio Dx Ltd.	1,034 Crore
3	Neuland Laboratories Ltd.	24,196 Crore
4	Max Healthcare Institute Ltd.	1,10,230 Crore
5	Novartis India Ltd.	3,602 Crore
6	Jupiter Life Line Hospitals Ltd.	9,570 Crore
7	Narayana Hrudayalaya Ltd.	40,882 Crore
8	Jagsonpal Pharmaceuticals Ltd.	1,560 Crore
9	Kwality Pharmaceuticals Ltd.	2,753 Crore
10	Global Health Ltd.	36,284 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,712	57,058	36.76	11.95	25.14	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,854	1,63,246	75.46	19.46	39.62	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,318	42,118	39.88	9.31	26.95	25.35
Lupin Ltd. (M)	Somewhat Good	2,490	1,13,963	21.37	5.08	12.36	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,153	1,14,518	22.72	4.40	13.90	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,477	82,615	97.06
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,421	38,385	46.04
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,854	1,63,246	43.21
Aurobindo Pharma Ltd. (M)	Very Good	1,583	91,709	33.87
Gland Pharma Ltd. (S)	Very Good	2,551	40,621	31.41
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,421	38,385	56.94	9.51	34.49	15.51
Mankind Pharma Ltd. (M)	Very Good	2,532	1,04,911	51.49	6.40	32.31	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,318	42,118	39.88	9.31	26.95	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,354	1,14,246	27.23	3.03	15.19	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,854	1,63,246	75.46	19.46	39.62	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,153	1,14,518	22.72	4.40	13.90	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,903	4,59,005	39.98	5.49	22.91	23.50
Abbott India Ltd. (M)	Very Good	26,712	57,058	36.76	11.95	25.14	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,354	1,14,246	27.23	3.03	15.19	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,263	64,072	47.05	6.10	12.50	14.41

You have 8 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about compliances-certificate

Concord Biotech informs about newspaper publication

Glenmark Pharmaceuticals informs about press release

Glenmark Pharmaceuticals’ arm launches Olanzapine for Injection

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn informs about disclosures

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.